𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Responses to adalimumab in psoriasis patients previously treated with anti–tumor necrosis factor agents: Subanalysis of BELIEVE

Book ID
116586439
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
50 KB
Volume
62
Category
Article
ISSN
1097-6787

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

B cell depletion may be more effective t
B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents
✍ Axel Finckh; Adrian Ciurea; Laure Brulhart; Diego Kyburz; Burkhard Möller; Silvi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) in whom the response to anti–tumor necrosis factor (anti‐TNF) therapy is inadequate have several therapeutic options, such as switching to an alternative anti‐TNF agent or initiating B cell–depleting therapy with rituximab (RTX). Alt

Decreased incidence of anterior uveitis
Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti–tumor necrosis factor agents infliximab and etanercept
✍ J. Braun; X. Baraliakos; J. Listing; J. Sieper 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

## Abstract ## Objective To estimate the incidence of anterior uveitis in patients with ankylosing spondylitis (AS) who underwent anti–tumor necrosis factor (anti‐TNF) therapy, using data from recently performed trials. ## Methods Data from 4 placebo‐controlled studies with anti‐TNF agents in AS